>> Monday
>> Tuesday
>> Wednesday
09:00 - 17:00
PCC01: Past, current and future perspectives in non-obstructive azoospermia
Sunday 29 June 2025
09:00 - 17:00: PCC01: Past, current and future perspectives in non-obstructive azoospermia:
Session 1: Management of non-obstructive azoospermia (NOA)
Alberto Pacheco Castro, Spain
Meurig Gallagher, United Kingdom
09:00 - 09:30
Clinical and ultrasound evaluation of NOA males
09:30 - 10:00
Predictors of successful sperm retrieval in NOA
10:30 - 11:00
Coffee break
11:00 - 11:30
Genetics of non-obstructive azoospermia: from karyotyping to whole-exome sequencing
Csilla Gabriella Krausz, Italy
11:45 - 12:15
Mechanisms of cellular dysfunction in testes from men with non-obstructive azoospermia
12:30 - 13:30
Lunch break
Session 3: From sperm retrieval to ICSI outcome in NOA
13:30 - 14:00
Testicular sperm extraction (TESE) versus micro-TESE
14:15 - 14:45
ICSI outcome and progeny health using testicular spermatozoa
15:00 - 15:30
Coffee break
Session 4: How to improve sperm retrieval in NOA?
15:30 - 15:50
Medical treatment in NOA to improve sperm retrieval
16:00 - 16:20
Genetic phenotype correlation in non-obstructive azoospermia and therapeutics options
16:30 - 17:00
Discussion of all content of day
09:00 - 17:00
PCC02: The devil is in the details
09:00 - 17:00: PCC02: The devil is in the details:
Ioannis Sfontouris, Greece
Giovanni Coticchio, Italy
09:00 - 09:30
Devil's guide to perfect media preparation
09:45 - 10:15
At the heart of fertilisation: molecular dynamics of the sperm-egg interaction
10:30 - 11:00
Coffee break
Maria Jose De Los Santos, Spain
11:00 - 11:30
The art of insemination: a clinical perspective
Sofia Makieva, Switzerland
11:45 - 12:15
Demonic precision in micromanipulation
Gemma Arroyo Cardona, Spain
12:30 - 13:30
Lunch break
Amy Barrie, United Kingdom
13:30 - 14:00
Embryo health revealed: profiling for success
14:15 - 14:45
Embryo transfer decoded: a comprehensive guide
Ioannis Sfontouris, Greece
15:00 - 15:30
Coffee break
Gemma Arroyo Cardona, Spain
15:30 - 16:00
Pitfalls and margins for improvement of oocyte vitrification
16:15 - 16:45
Devilishly effective: mastering lab management and KPIs
Amy Barrie, United Kingdom
09:00 - 17:00
PCC03: Endometriosis: a lifetime story
09:00 - 17:00: PCC03: Endometriosis: a lifetime story:
Antonio Simone Laganà, Italy
Dharani Hapangama, United Kingdom
09:00 - 09:30
Risk factors, epidemiology and diagnostic delay
09:45 - 10:15
Genetics and endometriosis
Krina Zondervan, United Kingdom
10:30 - 11:00
Coffee break
11:00 - 11:30
Non invasive biomarkers
11:45 - 12:15
Ultrasound and emerging AI techniques
12:30 - 13:30
Lunch break
Umberto Leone Roberti Maggiore, Italy
Chairperson to be announced
13:30 - 14:00
Can we prevent endometriosis and its recurrence?
14:15 - 14:45
Adolescent patients
Annemiek Nap, The Netherlands
15:00 - 15:30
Coffee break
Antonio Simone Laganà, Italy
15:30 - 16:00
Menopause patients
Christian Becker, United Kingdom
16:15 - 16:45
Endometriosis and cancer risk
Umberto Leone Roberti Maggiore, Italy
09:00 - 17:00
PCC04: Adult stem cells: A valuable resource for addressing reproductive health questions?
09:00 - 17:00: PCC04: Adult stem cells: A valuable resource for addressing reproductive health questions?:
Session 1: Bioengineered tissues, in vitro gametogenesis and the power of somatic cells
Jan-Bernd Stukenborg, Sweden
Nicola Williams, United Kingdom
09:00 - 09:30
Building a stem cell-based primate uterus
Christopher Penfold, United Kingdom
09:45 - 10:15
Generating gametes from iPSCs and the impact of the somatic niche
10:30 - 11:00
Coffee break
Session 2: Reproductive futures: ethical reflections on potential treatments derived from stem cells
Francesca Gioia Klinger, Italy
Cathy Herbrand, United Kingdom
11:00 - 11:30
Bioengineered reproductive tissue and uterine factor infertility: implications for current and developing treatment pathways
Nicola Williams, United Kingdom
11:45 - 12:15
Balancing the ethical pros and cons of stem cell derived gametes
12:30 - 13:30
Lunch break
Session 3: Disease models and potential treatment options in future
João Pedro Alves Lopes, Sweden
Chairperson to be announced
13:30 - 14:00
X-chromosome inactivation in Klinefelter patients iPS cells and its impact on early PGC, development
14:15 - 14:45
Adult stem cells in pre-pubertal klinefelter patients and potential clinical implications
Cristina Eguizabal, Spain
15:00 - 15:30
Coffee break
Luciana Cacciottola, France
15:30 - 16:00
Patents & human embryonic related technologies in Europe: a focus on ethics, equity and broader policy considerations
16:15 - 16:45
Induced pluripotent stem cells and embryo models: navigating national restrictions on the creation of embryos for research
Ana Pereira Daoud, The Netherlands
PCC05: Fertility preservation of gonadal tissue: putting theory into practices
: PCC05: Fertility preservation of gonadal tissue: putting theory into practices:
Session 1: How can cryopreservation protocols be optimized?
Isabelle Demeestere, Belgium
Chairperson to be announced
09:00 - 09:30
For ovarian tissue
Stine Gry Kristensen, Denmark
09:45 - 10:15
For testicular tissue
Kathleen Duffin, United Kingdom
10:30 - 11:00
Coffee break
Session 2: Is there an established protocol for gonadal tissue transplantation?
Rod Mitchell, United Kingdom
Kirsten Louise Tryde Macklon, Denmark
11:00 - 11:30
For ovarian tissue
Michael von Wolff, Switzerland
11:45 - 12:15
For testicular tissue
12:30 - 13:30
Lunch break
Session 3: Fertility preservation outcomes: how to get a pregnancy?
Claudia Massarotti, Italy
13:30 - 14:00
What is the most effective way to achieve pregnancy after tissue transplantation?
Lotte Berdiin Colmorn, Denmark
14:15 - 14:45
Who are the patients who return to use the cryopreserved material?
Isabelle Demeestere, Belgium
15:00 - 15:30
Coffee break
Session 4: Alternatives to gonadal tissue transplantation
Stine Gry Kristensen, Denmark
Aurélie Rives-Feraille, France
15:30 - 16:00
In vitro growth and ovarian tissue culture
16:15 - 16:45
In vitro spermatogenesis
Christine Rondanino, France
09:00 - 17:00
PCC06: Children conceived using donor gametes: communication, experiences, and psychosocial aspects of knowing one’s genetic background
09:00 - 17:00: PCC06: Children conceived using donor gametes: communication, experiences, and psychosocial aspects of knowing one’s genetic background:
Mariana Moura-Ramos, Portugal
Alexandra Claire Benoit, France
09:00 - 09:30
Disclosure in contemporary context
Sophie Zadeh, United Kingdom
09:45 - 10:15
Why to counsel patients using third-party reproduction to disclosure
10:30 - 11:00
Coffee break
11:00 - 11:30
Perspectives and experiences with direct-to-consumer dna-testing
11:45 - 12:15
Psychosocial outcomes of families formed through third-party reproduction after disclosure
Vasanti Jadva, United Kingdom
12:30 - 13:30
Lunch break
Denisa Marina Protopopescu, Romania
Verena Ehrbar, Switzerland
13:30 - 14:00
How to counsel families to disclosure: clinical point of view
14:15 - 14:45
Education and counseling for parents via the digital TELL tool: what we’ve learned and what’s next
Patricia Hershberger, U.S.A.
15:00 - 15:30
Coffee break
Karen Henriette Kirchheiner Jensen, Denmark
15:30 - 16:00
Experiences of a donor-conceived child - a lifelong condition
16:15 - 16:45
Experiences of parents who conceived with third-party reproduction
09:00 - 17:00
PCC07: From conception to choice: pregnancy loss, abortion and patient support
09:00 - 17:00: PCC07: From conception to choice: pregnancy loss, abortion and patient support:
Session 1 – Abortion care – from legal frameworks to clinical management
09:00 - 09:30
Legal frameworks for abortion access around the world: understanding global perspectives and challenges
Marge Berer, United Kingdom
09:45 - 10:15
Improving care for those seeking abortion: efficacy, safety, and patient experience
Kristina Gemzell - Danielsson, Sweden
10:30 - 11:00
Coffee break
Session 2 – Evidence-based care
Linda Stevens Brentjens, The Netherlands
11:00 - 11:30
Management options for threatened miscarriage
Ingrid Granne, United Kingdom
11:45 - 12:15
Biochemical vs. clinical pregnancy loss – two of a kind?
Henriette Svarre Nielsen, Denmark
12:30 - 13:30
Lunch break
Session 3 – Let’s talk about it!?
Henriette Svarre Nielsen, Denmark
Nicola Tempest, United Kingdom
13:30 - 14:00
Educational strategies in reproductive health
Joyce Harper, United Kingdom
14:15 - 14:45
Building predictive diagnostic models for reproductive health: using data and AI to improve outcomes
Helen O'Neill, United Kingdom
15:00 - 15:30
Coffee break
Session 4 – At the roots of pregnancy loss
15:30 - 16:00
The role of genetics in pregnancy loss: understanding risk factors and counseling patients
16:15 - 16:45
The theory of the human endometrium as a sensor of embryo quality: 10 years later
Jan Brosens, United Kingdom
09:00 - 17:00
PCC08: Navigating through the extremes of ovarian response
09:00 - 17:00: PCC08: Navigating through the extremes of ovarian response:
Session 1: Basic endocrinology: from bench to bedside
Chairperson to be announced
09:00 - 09:20
Do all gonadotrophins have the same effect
09:30 - 09:50
POI: have we cracked the code? The pathophysiological mechanisms of POI
10:00 - 10:20
Background of follicular crowding in PCOS? Why do PCO patients have so many follicles?
10:30 - 11:00
Coffee break
Session 2: Inducing ovulation and superovulation for highs
Christophe Blockeel, Belgium
11:00 - 11:20
The lost ART of ovulation induction. Is ovulation induction still relevant in 2025 in PCOS women?
11:30 - 11:50
Ovarian stimulation: mild vs wild in high responders
12:00 - 12:20
Clinical insights in ovarian stimulation with AI
Nikolaos P. Polyzos, Spain
12:30 - 13:30
Lunch break
Session 3: Tips and tricks for highs and lows
Christophe Blockeel, Belgium
13:30 - 15:00
Case discussions - panel - SIG reproductive endocrionology
Case discussions - panel - SIG reproductive endocrionology
Ying C. Cheong, United Kingdom
Case discussions - panel - SIG reproductive endocrionology
Biljana Popovic - Todorovic, Serbia
Case discussions - panel - SIG reproductive endocrionology
Case discussions - panel - SIG reproductive endocrionology
Case discussions - panel - SIG reproductive endocrionology
15:00 - 15:30
Coffee break
Session 4: Innovative approaches for highs and lows: hype or hope?
15:30 - 15:50
Mild versus wild in low responders
Biljana Popovic - Todorovic, Serbia
16:00 - 16:20
Intraovarian PRP: is it a matter of rejuvenation or reactivation?
Gorka Barrenetxea Ziarrusta, Spain
16:30 - 16:50
Time to reconsider IVM for high responders? Cost effectiveness
09:00 - 17:00
PCC09: Genetic causes of reproductive failure and their consequences on health
09:00 - 17:00: PCC09: Genetic causes of reproductive failure and their consequences on health:
Session 1: Genetics of infertility: a look at female and male factors
09:00 - 09:30
Monogenic gene–disease relationships in human female infertility and differences in sex development
09:45 - 10:15
The genes behind male infertility
Albert Salas-Huetos, Spain
10:30 - 11:00
Coffee break
Session 2: Chromosomal alterations in embryo arrest and miscarriages
Alberto Sola-Leyva, Sweden
11:00 - 11:30
Chromosomal abnormalities as a cause of arrest in in vitro fertilized human preimplantation embryos
Christian Simon Ottolini, Italy
11:45 - 12:15
Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss
12:30 - 13:30
Lunch break
Session 3: Beyond chromosomes
Noemi Castelluccio, Belgium
13:30 - 14:00
The multiple origins of genome instability during embryonic development
Tommaso Cavazza, Switzerland
14:15 - 14:45
Molecular mechanisms driving genomic rearrangement and developmental arrest in embryos
15:00 - 15:30
Coffee break
Session 4: Detection and contribution of lethal variants in reproductive failure
Efthymia Constantinou, Cyprus
15:30 - 16:00
Genetic and non-genetic causes of pregnancy loss
Henriette Svarre Nielsen, Denmark
16:15 - 16:45
Essential genes and their role in lethal phenotypes and infertility
Pilar Cacheiro, United Kingdom
09:00 - 17:00
PCC10: Hysteroscopy in infertile women: mastering clinical efficiency
09:00 - 17:00: PCC10: Hysteroscopy in infertile women: mastering clinical efficiency:
Attila Vereczkey, Hungary
09:00 - 09:30
From PANTALEONI until today
09:45 - 10:15
Hysteroscopic instrumentation, ergonomy and safety: what we need to know
Angelos Daniilidis, Greece
10:30 - 11:00
Coffee break
Attila Vereczkey, Hungary
11:00 - 11:30
Office hysteroscopy: choices and limits
11:45 - 12:15
Tissue mechanical removal systems
12:30 - 13:30
Lunch break
Chairperson to be announced
13:30 - 14:00
To scratch or not to scratch?
Attila Vereczkey, Hungary
14:15 - 14:45
Hysteroscopic management of uterine septum-reproductive outcome
15:00 - 15:30
Coffee break
Angelos Daniilidis, Greece
15:30 - 16:00
When it turns to be a nightmare: how to manage serious complications
Attilio Di Spiezio Sardo, Italy
16:15 - 16:45
Accreditation in hysteroscopy- GESEA-ECRES certification
09:00 - 17:00
PCC11: Immunomodulation during ART. A thing of the past or the answer to optimise treatment outcomes?
09:00 - 17:00: PCC11: Immunomodulation during ART. A thing of the past or the answer to optimise treatment outcomes?:
Nicholas Macklon, United Kingdom
09:00 - 09:30
An overview of the immune response to conception and implantation
Sarah A. Robertson, Australia
09:45 - 10:15
Can we be reproductively incompatible?
Jukka Kekäläinen, Finland
10:30 - 11:00
Coffee break
Bryan Woodward, United Kingdom
Chairperson to be announced
11:00 - 11:30
Empirical use of immune drugs: What does the RIF guideline suggest?
Nicholas Macklon, United Kingdom
11:45 - 12:15
Safety of immune therapies
Sarah A. Robertson, Australia
12:30 - 13:30
Lunch break
Samuel Dos Santos-Ribeiro, Portugal
13:30 - 14:00
KIR/HLA-C profiling in autologous and donor cycles
Meda Diana Alecsandru Danceanu, Spain
14:00 - 14:30
There is no evidence to suppress the immune system in ART
Ashley Moffett, United Kingdom
15:00 - 15:30
Coffee break
Aleksej Stevanovic, Norway
15:30 - 16:00
Uterine NK cells environment in endometrium
16:15 - 16:45
Chronic endometritis and microbiota assessment - is it something real?
José Antonio Horcajadas Almansa, Spain
09:00 - 17:00
PCC12: Academic Authorship: Milestones in reproductive science: highlights from ESHRE journals
09:00 - 17:00: PCC12: Academic Authorship: Milestones in reproductive science: highlights from ESHRE journals:
Kirstine Kirkegaard, Denmark
Chris Barratt, United Kingdom
09:00 - 09:30
Paternal age, de novo mutations, and offspring health? new directions for an ageing problem
Robert John Aitken, Australia
09:45 - 10:15
Genetic aspects of male infertility
Frank Tüttelmann, Germany
10:30 - 11:00
Coffee break
Madelon Van Wely, The Netherlands
Basil C. Tarlatzis, Greece
11:00 - 11:30
Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries.
11:45 - 12:15
Contribution of semen to early embryo development: fertilization and beyond
12:30 - 13:30
Lunch break
Session 3: MHR selection: Gaining control of human folliculogenesis in vivo and in vitro
13:30 - 14:00
Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment’
Bart C.J.M. Fauser, The Netherlands
14:15 - 14:45
Metaphase II oocytes from human unilaminar follicles grown in a multi-step culture system
Evelyn E. Telfer, United Kingdom
15:00 - 15:30
Coffee break
Edgardo Somigliana, Italy
15:30 - 16:00
The role of haemoperitoneum in endometriosis progression
Davor Jurkovic, United Kingdom
16:15 - 16:45
Theratogenic effects of dydrogesterone
09:00 - 12:00
PCC13: ASRM Exchange course: Embryo transfer (half day: morning)
09:00 - 12:00: PCC13: ASRM Exchange course: Embryo transfer (half day: morning):
09:00 - 09:05
Welcome – course overview
09:05 - 09:50
Current embryo transfer practice: standardizing the embryo transfer protocol
09:50 - 10:10
Embryo transfer: the role of the embryologist
Elizabeth Ginsburg, U.S.A.
10:10 - 10:30
Discussion/ Q&A
10:30 - 11:00
Coffee break
11:00 - 12:30
Hands-on simulator training
12:30 - 13:30
Lunch break
09:00 - 09:05
Welcome – course overview
09:05 - 10:30
Hands-on simulator training
10:30 - 11:00
Coffee break
11:00 - 11:50
Current embryo transfer practice: standardizing the embryo transfer protocol
11:50 - 12:10
Embryo transfer: the role of the embryologist
Elizabeth Ginsburg, U.S.A.
12:10 - 12:30
Discussion/ Q&A
12:30 - 13:30
Lunch break
13:30 - 17:00
PCC13b: ASRM Exchange course: Embryo transfer (half day: Afternoon)
13:30 - 17:00: PCC13b: ASRM Exchange course: Embryo transfer (half day: Afternoon):
13:30 - 13:35
Welcome – course overview
13:35 - 14:20
Current embryo transfer practice: standardizing the embryo transfer protocol
14:20 - 14:40
Embryo transfer: the role of the embryologist
Elizabeth Ginsburg, U.S.A.
14:40 - 15:00
Discussion/ Q&A
15:00 - 15:30
Coffee break
15:30 - 17:00
Hands-on simulator training
13:30 - 13:35
Welcome - course overview
13:35 - 15:00
Hands-on simulator training
15:00 - 15:30
Coffee break
15:30 - 16:15
Current embryo transfer practice: standardizing the embryo transfer protocol
16:15 - 16:35
Embryo transfer: the role of the embryologist
Elizabeth Ginsburg, U.S.A.
16:35 - 17:00
Discussion/ Q&A
09:00 - 17:00
PCC14: MEFS Exchange course: Breaking barriers in ovarian stimulation: from theory to practice
09:00 - 17:00: PCC14: MEFS Exchange course: Breaking barriers in ovarian stimulation: from theory to practice:
Chairperson to be announced
09:00 - 09:30
IVF pretreatment strategies: unlocking their uses and benefits strategies
09:45 - 10:15
LH supplementation: timing it right for optimal results
Yacoub Khalaf, United Kingdom
10:30 - 11:00
Coffee break
Yacoub Khalaf, United Kingdom
11:00 - 11:30
Hormonal monitoring in IVF: key metrics and their impact
Ying C. Cheong, United Kingdom
11:45 - 12:15
Random start protocols: expanding opportunities in IVF
Baris Ata, United Arab Emirates
12:30 - 13:30
Lunch break
Yacoub Khalaf, United Kingdom
13:30 - 14:00
Oral stimulation agents in IVF: a cost-effective approach?
14:15 - 14:45
Rethinking pituitary suppression: progestin-primed and beyond
Nikolaos P. Polyzos, Spain
15:00 - 15:30
Coffee break
Michel Abou Abdallah, Lebanon
15:30 - 16:00
GnRH agonist triggering: the latest innovations
16:15 - 16:45
Egg cryopreservation for cancer patients: safe and effective stimulation strategies
Kirsten Louise Tryde Macklon, Denmark